Company Filing History:
Years Active: 1999-2003
Title: David A Griffiths-Johnson: Innovator in Eotaxin-Specific Antibodies
Introduction
David A Griffiths-Johnson is a notable inventor based in London, GB. He has made significant contributions to the field of biomedical research, particularly in the development of therapies for asthma and other inflammatory diseases. With a total of four patents to his name, his work has the potential to impact many lives.
Latest Patents
Among his latest patents, Griffiths-Johnson has focused on eotaxin-specific antibodies. Eotaxin is a chemoattractant protein that plays a crucial role in attracting eosinophils, which are white blood cells involved in the inflammatory response. His research indicates that various agents that inhibit or hinder the production, release, or activity of eotaxin may be therapeutically beneficial in treating asthma and other inflammatory conditions.
Career Highlights
Griffiths-Johnson is affiliated with the Imperial College of Science, Technology and Medicine, where he conducts his research. His work has garnered attention for its innovative approach to addressing complex health issues. His patents reflect a commitment to advancing medical science and improving patient outcomes.
Collaborations
He has collaborated with esteemed colleagues, including Timothy J Williams and Peter J Jose. These partnerships have likely contributed to the depth and breadth of his research, enhancing the impact of his inventions.
Conclusion
David A Griffiths-Johnson stands out as an influential inventor in the realm of biomedical innovation. His work on eotaxin-specific antibodies showcases his dedication to developing effective treatments for inflammatory diseases. His contributions are paving the way for future advancements in medical therapies.